These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25142121)

  • 1. Effects of structured heart failure disease management on mortality and morbidity depend on patients' mood: results from the Interdisciplinary Network for Heart Failure Study.
    Gelbrich G; Störk S; Kreißl-Kemmer S; Faller H; Prettin C; Heuschmann PU; Ertl G; Angermann CE
    Eur J Heart Fail; 2014 Oct; 16(10):1133-41. PubMed ID: 25142121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative potential of the 2-item versus the 9-item patient health questionnaire to predict death or rehospitalization in heart failure.
    Piepenburg SM; Faller H; Gelbrich G; Störk S; Warrings B; Ertl G; Angermann CE
    Circ Heart Fail; 2015 May; 8(3):464-72. PubMed ID: 25878325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study.
    Angermann CE; Störk S; Gelbrich G; Faller H; Jahns R; Frantz S; Loeffler M; Ertl G;
    Circ Heart Fail; 2012 Jan; 5(1):25-35. PubMed ID: 21956192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom patterns and clinical outcomes in women versus men with systolic heart failure and depression.
    Piepenburg SM; Faller H; Störk S; Ertl G; Angermann CE
    Clin Res Cardiol; 2019 Mar; 108(3):244-253. PubMed ID: 30097684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study.
    Neumann A; Mostardt S; Biermann J; Gelbrich G; Goehler A; Geisler BP; Siebert U; Störk S; Ertl G; Angerrmann CE; Wasem J
    Clin Res Cardiol; 2015 Apr; 104(4):304-9. PubMed ID: 25403774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).
    Wong CM; Hawkins NM; Jhund PS; MacDonald MR; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Petrie MC; McMurray JJ
    J Am Coll Cardiol; 2013 Nov; 62(20):1845-54. PubMed ID: 23850914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Self-Management Interventions Work in Patients With Heart Failure? An Individual Patient Data Meta-Analysis.
    Jonkman NH; Westland H; Groenwold RH; Ågren S; Atienza F; Blue L; Bruggink-André de la Porte PW; DeWalt DA; Hebert PL; Heisler M; Jaarsma T; Kempen GI; Leventhal ME; Lok DJ; Mårtensson J; Muñiz J; Otsu H; Peters-Klimm F; Rich MW; Riegel B; Strömberg A; Tsuyuki RT; van Veldhuisen DJ; Trappenburg JC; Schuurmans MJ; Hoes AW
    Circulation; 2016 Mar; 133(12):1189-98. PubMed ID: 26873943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression predicts repeated heart failure hospitalizations.
    Johnson TJ; Basu S; Pisani BA; Avery EF; Mendez JC; Calvin JE; Powell LH
    J Card Fail; 2012 Mar; 18(3):246-52. PubMed ID: 22385946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study.
    Angermann CE; Kaspar M; Marx A; Kittel-Schneider S; Menhofer D; Störk S; Ertl G; Domschke K; Deckert J; Reif A
    Eur J Heart Fail; 2017 Mar; 19(3):314-323. PubMed ID: 27990720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial.
    Payvar S; Spertus JA; Miller AB; Casscells SW; Pang PS; Zannad F; Swedberg K; Maggioni AP; Reid KJ; Gheorghiade M;
    Eur J Heart Fail; 2013 Dec; 15(12):1382-9. PubMed ID: 23858000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telephonic case-finding of major depression in a Medicaid chronic disease management program for diabetes and heart failure.
    Ackermann RT; Rosenman MB; Downs SM; Holmes AM; Katz BP; Li J; Zillich AJ; Carney CP; Inui TS
    Gen Hosp Psychiatry; 2005; 27(5):338-43. PubMed ID: 16168794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of the association between depressive symptoms and long-term mortality in heart failure.
    Zuluaga MC; Guallar-Castillón P; Rodríguez-Pascual C; Conde-Herrera M; Conthe P; Rodríguez-Artalejo F
    Am Heart J; 2010 Feb; 159(2):231-7. PubMed ID: 20152221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Health Questionnaire-2 Screening for Depressive Symptoms in Japanese Outpatients with Heart Failure.
    Suzuki T; Shiga T; Nishimura K; Omori H; Tatsumi F; Hagiwara N
    Intern Med; 2019 Jun; 58(12):1689-1694. PubMed ID: 30799347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence rates and predictors of major and minor depression in patients with heart failure.
    Lossnitzer N; Herzog W; Störk S; Wild B; Müller-Tasch T; Lehmkuhl E; Zugck C; Regitz-Zagrosek V; Pankuweit S; Maisch B; Ertl G; Gelbrich G; Angermann CE;
    Int J Cardiol; 2013 Jul; 167(2):502-7. PubMed ID: 22341693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact and optimal timing of the Patient Health Questionnaire depression screen on 4-year mortality among hospitalized patients with systolic heart failure.
    Deveney TK; Belnap BH; Mazumdar S; Rollman BL
    Gen Hosp Psychiatry; 2016; 42():9-14. PubMed ID: 27638965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A positive 2-item Patient Health Questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality.
    Rollman BL; Herbeck Belnap B; Mazumdar S; Houck PR; He F; Alvarez RJ; Schulberg HC; Reynolds CF; McNamara DM
    J Card Fail; 2012 Mar; 18(3):238-45. PubMed ID: 22385945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.